The emerging role of leptin antagonist as potential therapeutic option for inflammatory bowel disease

International Reviews of Immunology

Volumn 33, Issue 1, 2014, Pages 23-33

  Singh, Udai P ^a   Singh, Narendra P ^a   Guan, Hongbing ^a   Busbee, Brandon ^a   Price, Robert L ^b   Taub, Dennis D ^c   Mishra, Manoj K ^d   Fayad, Raja ^b   Nagarkatti, Mitzi ^a   Nagarkatti, Prakash S ^a  

^a UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF SOUTH CAROLINA   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

^d ALABAMA STATE UNIVERSITY   (United States)

Author keywords

Crohn's disease (CD); Inflammation; Inflammatory bowel disease (IBD); Leptin antagonist; Pegylated leptin; Ulcerative colitis (UC)

Indexed keywords

LEPTIN; LEPTIN ANTAGONIST; PEPTIDE HORMONE ANTAGONIST; UNCLASSIFIED DRUG;

ADIPOSE TISSUE; AUTOIMMUNE DISEASE; BODY WEIGHT; CARCINOGENESIS; CARDIOVASCULAR DISEASE; CELLULAR IMMUNITY; ELEVATED BLOOD PRESSURE; ENTERITIS; HUMAN; IMMUNE RESPONSE; INFLAMMATORY BOWEL DISEASE; INTESTINE; LEPTIN DEFICIENCY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REVIEW;

ANIMALS; ANTI-INFLAMMATORY AGENTS; AUTOIMMUNE DISEASES; GASTROINTESTINAL TRACT; HUMANS; IMMUNITY, CELLULAR; INFLAMMATORY BOWEL DISEASES; LEPTIN; T-LYMPHOCYTES, REGULATORY;

EID: 84885450444     PISSN: 08830185     EISSN: 15635244     Source Type: Journal    
DOI: 10.3109/08830185.2013.809071     Document Type: Review

References (92)

1. Podolsky DK. Inflammatory bowel disease. N Engl JMed 2002;347:417-429
2. Podolsky DK. Inflammatory bowel disease (1). N Engl JMed 1991;325:928-937
3. Greenberg GR, Fleming CR, Jeejeebhoy KN, et al. Controlled trial of bowel rest and nutritional support in themanagement of Crohn's disease. Am J Clin Nutr 1989;49:573-579
4. Ehrhardt RO, Ludviksson BR, Gray B, et al. Induction and prevention of colonic inflammation in IL- 2-deficient mice. J Immunol 1997;158:566-573
5. Silk DB, Payne-James J. Inflammatory bowel disease: Nutritional implications and treatment. Proc Nutr Soc 1989;48:355-361
6. Rigaud D, Angel LA, Cerf M, et al. Mechanisms of decreased food intake during weight loss in adult Crohn's disease patients without obvious malabsorption. Am J Clin Nutr 1994;60: 775-781
7. De Gaetano A, Greco AV, Benedetti G, et al. Increased resting lipid oxidation in Crohn's disease. JPEN: J Parenter Enteral Nutr 1996;20:38-42
8. Powrie F, Leach MW. Genetic and spontaneous models of inflammatory bowel disease in rodents: Evidence for abnormalities inmucosal immune regulation.Ther Immunol 1995;2:115-123
9. Mombaerts P,Mizoguchi E, GrusbyMJ, et al. Spontaneous development of inflammatory bowel disease in T cell receptormutant mice. Cell 1993;75:274-282
10. Hollander GA, Simpson SJ,Mizoguchi E, et al. Severe colitis in mice with aberrant thymic selection. Immunity 1995;3:27-38
11. ElsonCO, Sartor RB, TennysonGS, Riddell RH. Experimentalmodels of inflammatory bowel disease. Gastroenterology 1995;109:1344-1367
12. Otero M, Lago R, Gomez R, et al. Towards a pro-inflammatory and immunomodulatory emerging role of leptin. Rheumatology (Oxford) 2006;45:944-950
13. Zhang Y. Positional cloning of the mouse obese gene and its human homologue. [see comments erratum appears in Nature 1995Mar 30;374(6521):479]. Nature 1994;372:425-432
14. Auwerx J, Staels B. Leptin. Lancet 1998;351:737-742
15. AhimaRS, Prabakaran D,MantzorosC, et al. Role of leptin in the neuroendocrine response to fasting. Nature 1996;382:250-252
16. Campfield LA, Smith FJ, Burn P. The OB protein (leptin) pathway - A link between adipose tissue mass and central neural networks. HormMetab Res 1996;28:619-632
17. Cioffi JA, Shafer AW, Zupancic TJ, et al. Novel B219/OB receptor isoforms: Possible role of leptin in hematopoiesis and reproduction. NatMed 1996;2:585-589
18. Grunfeld C, Zhao C, Fuller J, et al. Endotoxin and cytokines induce expression of leptin, the ob gene product, in hamsters. J Clin Invest 1996;97:2152-2157
19. Ning W, Dantzer R, Freund GG, et al. In vivo and in vitro evidence for the involvement of tumor necrosis factor-alpha in the induction of leptin by lipopolysaccharide. J Immunol 1998;160: 1393-1401
20. Shigenaga J, Moser A, Feingold KR, et al. IL-1 beta mediates leptin induction during inflammation. Biochem Biophys Res Commun 1998;244:75-78
21. Kohl B, Zumbach MS, Borcea V, et al. Tumor necrosis factor increases serumleptin levels in humans. Diabetes Care 1997;20:1880-1886
22. Halaas JL, Friedman JM, Chait BT, et al. Weight-reducing effects of the plasma protein encoded by the obese gene. [see comments.]. Science 1995;269(5223):543-546
23. Sobhani I, Bado A, Vissuzaine C, et al. Leptin secretion and leptin receptor in the human stomach. Gut 2000;47:178-183
24. BarattaM, Saleri R,Mainardi GL, et al. Leptin regulates GH gene expression and secretion and nitric oxide production in pig pituitary cells. Endocrinology 2002;143:551-557
25. Dong Z, Xu X, Du L, et al. Leptin-mediated regulation ofMT1-MMP localization is KIF1B dependent and enhances gastric cancer cell invasion. Carcinogenesis 2013;34(5):974-983
26. Deboer MD, Li Y. Puberty is delayed in male mice with dextran sodium sulfate colitis out of proportion to changes in food intake, body weight, and serum levels of leptin. Pediatr Res 2011;69: 34-39
27. BarbierM, Cherbut C, Aube AC, et al. Elevated plasma leptin concentrations in early stages of experimental intestinal inflammation in rats. Gut 1998;43:783-790
28. Weigle DS, Duell PB, Connor WE, et al. Effect of fasting, refeeding, and dietary fat restriction on plasma leptin levels. J Clin EndocrinolMetab 1997;82:561-565
29. Considine RV, Sinha MK, Heiman ML, et al. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl JMed 1996;334:292-295
30. Gaetke LM, Oz HS, de Villiers WJ, et al.The leptin defense against wasting is abolished in the IL-2- deficient mousemodel of inflammatory bowel disease. J Nutr 2002;132:893-896
31. TuzunA,Uygun A, Yesilova Z, et al. Leptin levels in the acute stage of ulcerative colitis. JGastroenterol Hepatol 2004;19:429-432
32. Karmiris K, Koutroubakis IE, Xidakis C, et al. Circulating levels of leptin, adiponectin, resistin, and ghrelin in inflammatory bowel disease. Inflamm Bowel Dis 2006;12:100-105
33. Karmiris K, Koutroubakis IE, Kouroumalis EA. Leptin, adiponectin, resistin, and ghrelin-implications for inflammatory bowel disease.Mol Nutr Food Res 2008;52:855-866
34. Biesiada G, Czepiel J, Ptak-Belowska A, et al. Expression and release of leptin and proinflammatory cytokines in patients with ulcerative colitis and infectious diarrhea. J Physiol Pharmacol 2012;63:471-481
35. Caro JF, Sinha MK, Kolaczynski JW, et al. Leptin: The tale of an obesity gene. Diabetes 1996;45:1455-1462
36. Maffei M, Halaas J, Ravussin E, et al. Leptin levels in human and rodent: Measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. NatMed 1995;1:1155-1161
37. Fitzgerald BP, McManus CJ. Photoperiodic versus metabolic signals as determinants of seasonal anestrus in themare. Biol Reprod 2000;63:335-340
38. Hotamisligil GS, Arner P, Caro JF, et al. Increased adipose tissue expression of tumor necrosis factoralpha in human obesity and insulin resistance. J Clin Invest 1995;95:2409-2415
39. Breese EJ,MichieCA,Nicholls SW, et al. Tumor necrosis factor alpha-producing cells in the intestinal mucosa of children with inflammatory bowel disease. Gastroenterology 1994;106:1455-1466
40. Reimund JM, Wittersheim C, Dumont S, et al. Increased production of tumour necrosis factor-apha interleukin-1 beta, and interleukin-6 by morphologically normal intestinal biopsies from patients with Crohn's disease. Gut 1996;39:684-689
41. Powrie F, Leach MW, Mauze S, et al. Inhibition of Th1 responses prevents inflammatory bowel disease in scid mice reconstituted with CD45RBhi CD4+ T cells. Immunity 1994;1:553-562
42. Kirchgessner TG, Uysal KT, Wiesbrock SM, et al. Tumor necrosis factor-alpha contributes to obesity-related hyperleptinemia by regulating leptin release from adipocytes. J Clin Invest 1997;100:2777-2782
43. BarbierM,Vidal H,Desreumaux P, et al. Overexpression of leptinmRNAinmesenteric adipose tissue in inflammatory bowel diseases. Gastroenterol Clin Biol 2003;27:987-991
44. Sitaraman S, Liu X, Charrier L, et al. Colonic leptin: Source of a novel proinflammatory cytokine involved in IBD. FASEB J 2004;18:696-698
45. Aurangzeb B, Leach ST, Lemberg DA, Day AS. Assessment of nutritional status and serum leptin in children with inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2011;52:536-541
46. FranchimontD, Roland S,Gustot T, et al. Impact of infliximab on serumleptin levels in patientswith Crohn's disease. J Clin EndocrinolMetab 2005;90:3510-3516
47. Ballinger A, Kelly P, Hallyburton E, et al. Plasma leptin in chronic inflammatory bowel disease and HIV: Implications for the pathogenesis of anorexia and weight loss. Clin Sci (Lond) 1998;94:479-483
48. Lord GM,Matarese G, Howard JK, et al. Leptinmodulates the T-cell immune response and reverses starvation-induced immunosuppression. Nature 1998;394:897-901
49. Palmer G, Aurrand-LionsM, Contassot E, et al. Indirect effects of leptin receptor deficiency on lymphocyte populations and immune response in db/dbmice. J Immunol 2006;177:2899-2907
50. Mackey-Lawrence NM, Petri WA, Jr. Leptin and mucosal immunity. Mucosal Immunol 2012;5: 472-479
51. Howard JK, Lord GM,Matarese G, et al. Leptin protectsmice fromstarvation-induced lymphoid atrophy and increases thymic cellularity in ob/obmice. J Clin Invest 1999;104:1051-1059
52. Siegmund B, Lehr HA, Fantuzzi G. Leptin: A pivotal mediator of intestinal inflammation in mice. Gastroenterology 2002;122:2011-2025
53. Busso N, So A, Chobaz-Peclat V, et al. Leptin signaling deficiency impairs humoral and cellular immune responses and attenuates experimental arthritis. J Immunol. 2002;168:875-882
54. Bennett BD, Solar GP, Yuan JQ, et al. A role for leptin and its cognate receptor in hematopoiesis. Curr Biol 1996;6:1170-1180
55. Lord GM, Matarese G, Howard JK, et al. Leptin inhibits the anti-CD3-driven proliferation of peripheral blood T cells but enhances the production of proinflammatory cytokines. J Leuko Biol 2002;72:330-338
56. Mattioli B, Straface E, Quaranta MG, et al. Leptin promotes differentiation and survival of human dendritic cells and licenses them for Th1 priming. J Immunol 2005;174:6820-6828
57. Napoleone E, DI Santo A, Amore C, et al. Leptin induces tissue factor expression in human peripheral blood mononuclear cells: A possible link between obesity and cardiovascular risk? J Thromb Haemost 2007;5:1462-1468
58. Stofkova A. Leptin and adiponectin: From energy and metabolic dysbalance to inflammation and autoimmunity. Endo Regulat 2009;43:157-168
59. Zarkesh-Esfahani H, Pockley AG, Wu Z, et al. Leptin indirectly activates human neutrophils via induction of TNF-alpha. J Immunol 2004;172:1809-1814
60. Martin-Romero C, Santos-Alvarez J, Goberna R, et al. Human leptin enhances activation and proliferation of human circulating T lymphocytes. Cell Immunol 2000;199:15-24
61. Fernandez-Riejos P, Goberna R, Sanchez-Margalet V. Leptin promotes cell survival and activates Jurkat T lymphocytes by stimulation of mitogen-activated protein kinase. Clin Exp Immunol 2008;151:505-518
62. Fujita Y, Murakami M, Ogawa Y, et al. Leptin inhibits stress-induced apoptosis of T lymphocytes. Clin Exp Immunol 2002;128:21-26
63. Farooqi IS, Matarese G, Lord GM, et al. Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and neuroendocrine/metabolic dysfunction of human congenital leptin deficiency. J Clin Invest 2002;110:1093-1103
64. De Rosa V, Procaccini C, Cali G, et al. A key role of leptin in the control of regulatory T cell proliferation. Immunity 2007;26:241-255
65. Hasenkrug KJ. The leptin connection: Regulatory T cells and autoimmunity. Immunity 2007;26:143-145
66. Matarese G, Carrieri PB, La Cava A, et al. Leptin increase in multiple sclerosis associates with reduced number of CD4(+)CD25+ regulatory T cells. Proc Natl Acad Sci USA 2005;102:5150-5155
67. Coombes JL, Robinson NJ, Maloy KJ, et al. Regulatory T cells and intestinal homeostasis. Immunol Rev 2005;204:184-194
68. Read S,MalmstromV, Powrie F. Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation. J Exp Med 2000;192:295-302
69. Mottet C, Uhlig HH, Powrie F. Cutting edge: Cure of colitis by CD4+CD25+ regulatory T cells. J Immunol 2003;170:3939-3943
70. Matarese G, Di Giacomo A, Sanna V, et al. Requirement for leptin in the induction and progression of autoimmune encephalomyelitis. J Immunol 2001;166:5909-5916
71. Klingenberg R, Lebens M, Hermansson A, et al. Intranasal immunization with an apolipoprotein B-100 fusion protein induces antigen-specific regulatory T cells and reduces atherosclerosis. Arterioscler Thromb Vasc Biol 2010;30:946-952
72. Peelman F,Waelput W, Iserentant H, et al. Leptin: Linking adipocytemetabolismwith cardiovascular and autoimmune diseases. Prog Lip Res 2004;43:283-301
73. Bjorbaek C, Kahn BB. Leptin signaling in the central nervous system and the periphery. Rec Prog HormRes 2004;59:305-331
74. Gertler A. Development of leptin antagonists and their potential use in experimental biology and medicine. Tren EndocrinolMetab 2006;17:372-378
75. OzataM,Ozdemir IC, Licinio J.Humanleptindeficiency causedby amissensemutation:multiple endocrine defects, decreased sympathetic tone, and immune system dysfunction indicate new targets for leptin action, greater central than peripheral resistance to the effects of leptin, and spontaneous correction of leptin-mediated defects.[see comment][erratum appears in J Clin Endocrinol Metab 2000 Jan;85(1):416]. J Clin EndocrinolMetab 1999;84:3686-3695
76. Mykoniatis A, Anton PM,WlkM, et al. Leptin mediates Clostridium difficile toxin A-induced enteritis in mice. Gastroenterology 2003;124:683-691
77. Otvos L, Jr., Shao WH, Vanniasinghe AS, et al. Toward understanding the role of leptin and leptin receptor antagonism in preclinical models of rheumatoid arthritis. Peptides 2011;32: 1567-1574
78. Matarese G, Sanna V, Di Giacomo A, et al. Leptin potentiates experimental autoimmune encephalomyelitis in SJL female mice and confers susceptibility to males. Euro J Immunol 2001;31:1324-1332
79. Garcia-Gonzalea A, Gonzalez-lopez L, Valera-Gonzalez IC, et al. Serumleptin levels in women with systemic lupus erythematosus. Rhaumatol Int 2002;22:138-141
80. Rey LK, Wieczorek S, Akkad DA, et al. Polymorphisms in genes encoding leptin, ghrelin and their receptors in Germanmultiple sclerosis patients.Mol Cell Probes 2011;25:255-259
81. Matarese G, Sanna V, Lechler RI, et al. Leptin accelerates autoimmune diabetes in femaleNODmice. Diabetes 2002;51:1356-1361
82. Babaei A, Zarkesh-Esfahani SH, Bahrami E, Ross RJ. Restricted leptin antagonism as a therapeutic approach to treatment of autoimmune diseases. Hormones (Athens) 2011;10:16-26
83. Ducsay CA, Furuta K, Vargas VE, et al. Leptin receptor antagonist treatment ameliorates the effects of long-term maternal hypoxia on adrenal expression of key steroidogenic genes in the ovine fetus. Am J Physiol Regul Integr Comp Physiol 2013;304:R435-R442
84. Gionchetti P, Rizzello F, Venturi A, et al. Probiotics in infective diarrhoea and inflammatory bowel diseases ultrasonographic findings in Crohn's disease. [letter; comment.]. J Gastroenterol Hepatolo 2000;15:489-493
85. Singh UP, Singh S, Taub DD, Lillard JW, Jr. Inhibition of IFN-gamma-inducible protein-10 abrogates colitis in IL-10 (/) mice. J Immunol 2003;171:1401-1406
86. Salomon G, Niv-Spector L, Gussakovsky EE, Gertler A. Large-scale preparation of biologically active mouse and rat leptins and their L39A/D40A/F41Amuteinswhich act as potent antagonists. Prote Exp Purifica 2006;47:128-136
87. Rajapurohitam V, Javadov S, Purdham DM, et al. An autocrine role for leptin in mediating the cardiomyocyte hypertrophic effects of angiotensin II and endothelin-1. J Mol Cell Cardiol 2006;41:265-274
88. Zhang J, Matheny KM, Tumer N, et al. Leptin antagonist reveals that the normalization of caloric intake and the thermic effect of food after high-fat feeding are leptin dependent. Am J Physiol Regul Integr Comp Physiol 2007;292(2):R868-R874
89. Ducroc R, Guilmeau S, Akasbi K, et al. Luminal leptin induces rapid inhibition of active intestinal absorption of glucosemediated by sodium-glucose cotransporter 1. Diabetes 2005;54:348-354
90. Feuermann Y, Mabjeesh SJ, Niv-Spector L, et al. Prolactin affects leptin action in the bovine mammary gland via themammary fat pad. J Endocrinol 2006;191:407-413
91. Singh UP, Singh N, Singh B, et al. Pegylated leptin antagonist ameliorates colitis by inducing regulatoryT cells (Tregs) partially mediated byTGF-beta induction. J Immunol 2011;186:162.4-4 (Abstract
92. Singh UP, Singh NP, Guan H, et al. Leptin antagonist ameliorates chronic colitis in IL-10/ mice. Immunobiology 2013; S0171-2985 (13) 00095-8. doi: 10.1016/j.imbio.2013.04.020. [Epub ahead of print].